-
FIRST-LINE CDK4/6 INHIBITOR USE IN METASTATIC BREAST CANCER: REAL-WORLD DATA FROM A RETROSPECTIVE US COHORT STUDY
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF LEBRIKIZUMAB VERSUS NEMOLIZUMAB FOR MODERATE-TO-SEVERE ATOPIC DERMATITIS IN THE US: A 10-YEAR ECONOMIC EVALUATION
Mar 18, 2026, 21:38 PM -
POSTURAL CORRECTION IN PRIMARY SCHOOL CHILDREN AND THE EFFECTS OF SCHOOL BACKPACKS ON POSTURE
Mar 18, 2026, 21:38 PM -
REDESIGNING MUSCULOSKELETAL REFERRAL PATHWAYS IN EUROPE: SYSTEM-LEVEL EFFECTS OF A DIGITAL-SEROLOGY TRIAGE MODEL
Mar 18, 2026, 21:38 PM -
DEPRESSION AND HYPERTENSION AMONG U.S. ADULTS: A CROSS-SECTIONAL ANALYSIS OF NHANES DATA
Mar 18, 2026, 21:38 PM -
MEASURING MEANINGFUL ENGAGEMENT: A PATIENT ENGAGEMENT METRICS FRAMEWORK FOR PATIENT-GENERATED PRIMARY DATA QUALITY
Mar 18, 2026, 21:38 PM -
EXAMINING PATIENT AND TUMOR CHARACTERISTICS ASSOCIATED WITH THE RECEIPT OF NEOADJUVANT CHEMOTHERAPY (NAC) AMONG WOMEN WITH EARLY-STAGE HORMONE RECEPTOR-POSITIVE BREAST CANCER
Mar 18, 2026, 21:38 PM -
STRATEGIC COMPARISON OF CENTER FOR PHARMACOECONOMICS AND INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW ECONOMIC EVALUATIONS
Mar 18, 2026, 21:38 PM -
ADVANCING CANCER HEOR WITH A DECENTRALIZED, TRANSPARENT, AND INTERACTIVE OPEN SOURCE MODEL PLATFORM
Mar 18, 2026, 21:38 PM -
REAL-WORLD PRESCRIPTION PATTERNS, ADHERENCE, AND LDL REDUCTION OF PCSK9 INHIBITOR USERS IN CHINA: EVIDENCE FOLLOWING NRDL INCLUSION
Mar 18, 2026, 21:38 PM -
REAL-WORLD RISK OF ACUTE KIDNEY FAILURE AFTER SACUBITRIL/VALSARTAN VS ARB AMONG ADULTS =65 WITH HEART FAILURE
Mar 18, 2026, 21:38 PM -
A MULTI-INDICATION HEALTH TECHNOLOGY ASSESSMENT FRAMEWORK FOR ONCOLOGICAL DRUGS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM (SUS)
Mar 18, 2026, 21:38 PM -
WHAT CAN SOCIAL DRIVERS OF HEALTH DATA TELL US ABOUT HEALTH PLAN MEMBERS IN A LARGE REAL-WORLD DATABASE?
Mar 18, 2026, 21:38 PM -
DEVELOPING A PATIENT-REPORTED OUTCOME (PRO) MEASURE FOR JAPANESE PATIENTS WITH NON-METASTATIC CASTRATION RESISTANT PROSTATE CANCER (NMCRPC)
Mar 18, 2026, 21:38 PM -
ANALYSIS OF FDA REVIEW COMMENTS ON PATIENT-REPORTED OUTCOMES IN NEW DRUG APPLICATIONS(2021-2025)
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS OF PHARMACOLOGICAL TREATMENTS FOR STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE CHINESE POPULATION: A BAYESIAN NETWORK META ANALYSIS
Mar 18, 2026, 21:38 PM -
DISPARITY IMPLICATIONS OF MACHINE-LEARNING-BASED MTM ELIGIBILITY CRITERIA
Mar 18, 2026, 21:38 PM -
THE ROAD AHEAD: ARE U.S. PAYER POLICIES KEEPING PACE WITH RAPID INNOVATION IN ALZHEIMER'S DISEASE DIAGNOSTIC TESTING?
Mar 18, 2026, 21:38 PM -
IMPLEMENTATION OF EU JOINT CLINICAL ASSESSMENT: AN EARLY LANDSCAPE OF SUBMISSION PATTERNS AND HTA INVOLVEMENT
Mar 18, 2026, 21:38 PM -
USING EXTENDED COX MODELS WITH TIME-VARYING COVARIATES TO EXAMINE EFFECT OF VARIABLE OPIOID EXPOSURE IN CANCER RECURRENCE IN DISEASE-FREE BREAST CANCER SURVIVORS
Mar 18, 2026, 21:38 PM
